E4BP4/NFIL3 modulates the epigenetically repressed RAS effector RASSF8 function through histone methyltransferases

Area of Science:

• Molecular Oncology
• Epigenetics
• Cancer Biology

Background:

• RAS proteins are key oncogenes, with nonenzymatic RAS effectors (RASSF family) exhibiting tumor-suppressive roles.
• While most RASSF members are epigenetically silenced by hypermethylation, RASSF8 downregulation mechanisms in cancer remain unclear.

Purpose of the Study:

• To elucidate the mechanism of RASSF8 downregulation in cancer.
• To identify transcriptional modulators and epigenetic factors affecting RASSF8 expression.

Main Methods:

• Investigated the role of E4BP4 in regulating RASSF8 expression.
• Assessed the involvement of histone methyltransferases G9a and SUV39H1.
• Correlated RASSF8 and E4BP4 expression in breast tumor samples.

Main Results:

• Identified E4BP4 as a transcriptional repressor of RASSF8.
• Demonstrated that E4BP4 utilizes G9a and SUV39H1 to repress RASSF8 expression.
• Observed a negative correlation between RASSF8 and E4BP4 in breast tumors.
• Showed E4BP4 antagonizes RASSF8's anti-proliferative and pro-apoptotic effects.

Conclusions:

• E4BP4 epigenetically represses RASSF8 expression through histone methyltransferases.
• This mechanism contributes to RASSF8 downregulation in breast cancer.
• Findings provide insights into RASSF8 regulation and suggest therapeutic strategies.